Adiro



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 53.7%
Hypertension 10.6%
Prophylaxis 4.1%
Type 2 Diabetes Mellitus 4.1%
Angina Pectoris 3.3%
Myocardial Ischaemia 2.4%
Premedication 2.4%
Arrhythmia 1.6%
Arterial Stent Insertion 1.6%
Atrial Fibrillation 1.6%
Blood Pressure Increased 1.6%
Cardiac Failure Congestive 1.6%
Cholelithiasis 1.6%
Dyspepsia 1.6%
Essential Hypertension 1.6%
Hypercholesterolaemia 1.6%
Respiratory Tract Infection 1.6%
Rheumatoid Arthritis 1.6%
Atonic Seizures 0.8%
Atrial Septal Defect 0.8%
Thrombocytopenia 11.1%
Acute Prerenal Failure 7.4%
Melaena 7.4%
Renal Failure Acute 7.4%
Toxic Epidermal Necrolysis 7.4%
Vomiting 7.4%
Anaemia Haemolytic Autoimmune 3.7%
Diabetes Mellitus 3.7%
Duodenal Ulcer Haemorrhage 3.7%
Gastrointestinal Haemorrhage 3.7%
Hemiplegia 3.7%
Hepatitis 3.7%
Hepatitis Acute 3.7%
Leukocytoclastic Vasculitis 3.7%
Parotitis 3.7%
Rectal Haemorrhage 3.7%
Renal Failure 3.7%
Respiratory Acidosis 3.7%
Tubulointerstitial Nephritis 3.7%
Upper Gastrointestinal Haemorrhage 3.7%
Secondary
Drug Use For Unknown Indication 18.4%
Product Used For Unknown Indication 16.0%
Chronic Obstructive Pulmonary Disease 9.0%
Hypertension 8.6%
Cardiomyopathy 5.7%
Cough 5.7%
Prophylaxis 4.9%
Myocardial Ischaemia 4.1%
Acute Myocardial Infarction 3.7%
Atrial Fibrillation 3.7%
Cardiac Disorder 3.7%
Blood Test Abnormal 2.0%
Coronary Artery Disease 2.0%
Diabetes Mellitus 2.0%
Dyslipidaemia 2.0%
Acute Coronary Syndrome 1.6%
Cardiovascular Event Prophylaxis 1.6%
Hypercholesterolaemia 1.6%
Iron Deficiency Anaemia 1.6%
Osteoporosis 1.6%
Stevens-johnson Syndrome 13.7%
Suicide Attempt 9.8%
Toxic Epidermal Necrolysis 9.8%
Renal Tubular Necrosis 7.8%
Vomiting 7.8%
Gastrointestinal Haemorrhage 5.9%
Hepatitis Acute 5.9%
Upper Gastrointestinal Haemorrhage 5.9%
Anaemia 3.9%
Diabetes Mellitus 3.9%
Lactic Acidosis 3.9%
Rectal Haemorrhage 3.9%
Treatment Noncompliance 3.9%
Disease Progression 2.0%
Eye Haemorrhage 2.0%
Gastric Ulcer Haemorrhage 2.0%
Hepatitis 2.0%
Hepatitis Cholestatic 2.0%
Hypocoagulable State 2.0%
Infection Parasitic 2.0%
Concomitant
Hypertension 19.2%
Drug Use For Unknown Indication 10.8%
Osteoporosis 10.8%
Prophylaxis 9.8%
Diabetes Mellitus 8.5%
Cardiac Failure 4.7%
Product Used For Unknown Indication 4.4%
Type 2 Diabetes Mellitus 4.2%
Pain 4.1%
Depression 3.4%
Multiple Myeloma 3.2%
Colorectal Cancer 2.4%
Hypercholesterolaemia 2.4%
Cardiac Disorder 2.0%
Dyslipidaemia 2.0%
Insomnia 1.8%
Myocardial Ischaemia 1.7%
Anxiety 1.6%
Non-small Cell Lung Cancer 1.6%
Atrial Fibrillation 1.5%
Renal Failure Acute 15.1%
Vomiting 7.5%
Death 6.8%
Sepsis 5.5%
Hyperkalaemia 4.8%
Hyponatraemia 4.8%
Weight Decreased 4.8%
Aplasia Pure Red Cell 4.1%
Haemoptysis 4.1%
Pulmonary Oedema 4.1%
Respiratory Failure 4.1%
Septic Shock 4.1%
Serotonin Syndrome 4.1%
Somnolence 4.1%
Syncope 4.1%
Therapeutic Agent Toxicity 4.1%
Loss Of Consciousness 3.4%
Pancytopenia 3.4%
Pyrexia 3.4%
Renal Failure 3.4%
Interacting
Acute Coronary Syndrome 25.4%
Hypertension 9.2%
Prophylaxis 6.3%
Prophylaxis Against Gastrointestinal Ulcer 6.3%
Agitation 5.6%
Angina Pectoris 5.6%
Amnesia 4.2%
Cardiovascular Event Prophylaxis 4.2%
Depression 4.2%
Drug Use For Unknown Indication 4.2%
Acute Myocardial Infarction 3.5%
Atrial Fibrillation 3.5%
Type 2 Diabetes Mellitus 3.5%
Gastritis 2.1%
Hyperlipidaemia 2.1%
Ischaemic Cardiomyopathy 2.1%
Myocardial Ischaemia 2.1%
Pain 2.1%
Thrombosis 2.1%
Dyslipidaemia 1.4%
Syncope 20.6%
Hepatitis Cholestatic 17.6%
Upper Gastrointestinal Haemorrhage 14.7%
Drug Interaction 11.8%
Pulmonary Oedema 8.8%
Renal Failure Acute 8.8%
Renal Tubular Necrosis 5.9%
Melaena 2.9%
Subdural Haematoma 2.9%
Thrombotic Thrombocytopenic Purpura 2.9%
Urosepsis 2.9%